Induct AS (OSL:INDCT)
Norway
· Delayed Price · Currency is NOK 3.200
0.00 (0.00%)
At close: Mar 28, 2025
Induct AS Revenue
In the year 2024, Induct AS had annual revenue of 17.50M NOK, down -16.82%. Induct AS had revenue of 3.85M in the quarter ending December 31, 2024, a decrease of -21.47%.
Revenue
17.50M
Revenue Growth
-16.82%
P/S Ratio
4.79
Revenue / Employee
972.33K
Employees
18
Market Cap
83.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.50M | -3.54M | -16.82% |
| Dec 31, 2023 | 21.04M | 1.60M | 8.25% |
| Dec 31, 2022 | 19.44M | 5.13M | 35.85% |
| Dec 31, 2021 | 14.31M | 2.70M | 23.32% |
| Dec 31, 2020 | 11.60M | -2.18M | -15.84% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 562.60M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 525.39M |
| Vistin Pharma ASA | 429.50M |
| Hofseth BioCare ASA | 265.54M |
| Omda AS | 426.27M |
| ArcticZymes Technologies ASA | 108.11M |
| Nykode Therapeutics AS | 104.04M |